Study types
- article 4
- other 1
Condition tags
- endometriosis 5
- dysmenorrhea 1
Top journals
Frequent coauthors
- M. Zwirner 2
- H. Ochs 1
- K. Bühler 1
- Karl-Werner Schweppe 1
- L. Mettler 1
- Robert Koch 1
- A. E. Schindler 1
- U. Cirkel 1
A phase III multicentre study was carried out with the GnRH agonist buserelin (Suprecur) at five university institutions (Dept. of Obstetrics and Gynaecology of Essen, Kiel, Tübingen, Münster and Erlangen) to evaluate the effect of Busereli…
23 women of reproductive age were treated with Buserelin nose-spray for endometriosis, which had been diagnosed by laparoscopic and bioptic methods. The treatment period was 6 months. Various hormones in serum were determined after 2, 4, 8,…
Buserelin has been applied intranasal in 31 women of the reproductive age for endometriosis that had been diagnosed by laparoscopic and bioptic means. The treatment period was 6 month and hormonal changes were evaluated after 2, 4, 8, 12, 1…
We have treated 31 patients for 6 months at the UFK Tübingen. The AFS-score declined from 7.3 to 3.6, and the--for adhesions corrected--implantation-score from 3.5 to 0.5. Last decline was statistically significant. The endometriosis-specif…
We have treated 31 patients for 6 months at the UFK Tübingen. The AFS-score declined from 7.3 to 3.6, and the--for adhesions corrected--implantation-score from 3.5 to 0.5. Last decline was statistically significant. The endometriosis-specif…